
CEO Ellis resigns after 20 years at struggling drug firm Endocyte
The West Lafayette-based company has named CFO and COO Mike Sherman as new CEO and president, but did not give a reason for the abrupt change in leadership.
The West Lafayette-based company has named CFO and COO Mike Sherman as new CEO and president, but did not give a reason for the abrupt change in leadership.
Federal regulators are giving the proposed $48 billion merger between health insurers Anthem Inc. and Cigna Corp a hard look, and some analysts are hedging their bets.
Doctors who accept free meals from the pharmaceutical industry are more likely to prescribe certain branded drugs to Medicare patients than generics, according to a study published Monday.
The money will be awarded from IU’s Grand Challenges Program, a new push that is designed to tackle “major and large-scale problems facing humanity” that can only be addressed by multidisciplinary research teams.
The lawsuits against Cook Medical began four years ago with a trickle but have since turned into a gusher, now surpassing 500.
Animated Dynamics Inc. has raised $1.7 million in early funding to help it get its technology to market.
One of Indiana’s largest home health care providers, facing allegations that it put patients in immediate jeopardy, has agreed to be acquired by a competing company in a deal that could be worth as much as $3 million.
The competition heated up in the $71.5 billion global diabetes market last year after Indianapolis-based Eli Lilly’s and Boehringer Ingelheim’s Jardiance unexpectedly reduced the risk of heart attacks, strokes and deaths in a study.
State health officials are urging Indiana's health care providers to aggressively test patients for syphilis.
The state’s Family and Social Services Administration is set to cut home health care Medicaid reimbursements for licensed practical nurses, registered nurses, aides, therapists and pathologists.
Biochemist has founded or co-founded five startups since retiring from Eli Lilly and Co. as head of biotechnology research 13 years ago, at age 50.
The Indianapolis-based drugmaker said Tuesday it has built a robust pipeline of drugs that “has the potential” to launch 20 new products in the 10 years between 2014 and 2023.
A court-appointed patient care ombudsman who looked into Nightingale Home Healthcare’s operations says he found more than 1,300 complaints from patients and family members since 2011.
A Carmel surgery center is joining others in the state in suing UnitedHealthcare, alleging it unlawfully withheld payment for some services to make up for overpayment of other claims.
Indiana is one of several states involved in legal battles over the storage of blood samples. The cases pose a dilemma: How can society balance the right to privacy with the needs of science and medical research?
The founder of AIT Laboratories, along with his insurance companies and bank, will pay back more than $3 million to employees who bought the company from him six years ago at what the government said was an inflated price.
It’s been a roller-coaster ride for Indiana physicians and hospitals, with fees swinging wildly up and down in recent years to fund a state insurance program that helps pay malpractice awards.
The Indiana Blood Center said it has been forced to defer up to 30 percent of donors at some post-spring break blood drives because they had traveled to areas where the Zika virus is being transmitted.
A federal judge made the award to Lilly’s former executive director of human resources, who quit for health reasons and was later dropped from the company’s extended disability plan.
Deep cuts in Medicare reimbursements and competition from a few huge national chains and walk-in labs are making it tougher for Indianapolis-based AIT and other toxicology labs to compete.